Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14732 ↗At a glance
Journal article in ESC Heart Failure, 2024. Written by Yichao Xiao and 7 co-authors. Institution: Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China. Major MEDLINE topics: Subarachnoid Hemorrhage, Rats, Sprague-Dawley, Disease Models, Animal, Receptors, Neuropeptide Y. 19 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Provincial Natural Science Foundation of Hunan, Natural Science Foundation of Hunan Province.
Abstract (original language)
Aims
Cardiac dysfunction is commonly observed in patients with subarachnoid haemorrhage (SAH). However, the specific timeline of cardiac remodelling and the underlying mechanisms responsible for this effect following SAH remain unknown. This study aims to explore the impact of SAH on cardiac dysfunction and its potential mechanisms over time. Methods and results In Protocol 1, we investigated cardiac function and potential mechanisms in a Sprague-Dawley rat model of SAH at six time points (baseline and Days 1, 3, 7, 14, and 28) while exploring the underlying mechanisms. Our assessments included the haemodynamic profile, echocardiography, and the concentrations of plasma biomarkers at various time points post-SAH. We determined neuropeptide Y (NPY) 1–5 receptor protein expression levels through western blotting. In Protocol 2, we administered an NPY1 receptor antagonist to evaluate the effects of cardiac dysfunction induced by SAH on Day 3. In Protocol 1, SAH gradually provoked cardiac systolic dysfunction during the acute phase, reaching its peak on Day 3 without concurrent alterations in wall thickness. However, no significant changes were observed from Days 14 to 28 compared with Day 0. The changes in cardiac dysfunction were consistent with myocardial injury, inflammatory biomarkers, and NPY levels. SAH resulted in a heightened heart rate and systolic blood pressure, correlating with elevated epinephrine and norepinephrine levels. In Protocol 2, the administration of the NPY1 receptor antagonist effectively ameliorated cardiac dysfunction.
Conclusions
SAH induces transient cardiac dysfunction in the acute phase, and the underlying mechanisms for this response involve the NPY–NPY1 receptor pathway, otherwise known as catecholamines.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Renmin Hospital of Wuhan University, Wuhan, China.
ORCID profiles: Mingxian Chen
Funding
- National Natural Science Foundation of China
- Provincial Natural Science Foundation of Hunan
- Natural Science Foundation of Hunan Province
Cite
APA
Xiao, Y., Lai, X., Wang, Z., Wang, S., Wu, Z., Liu, Q., Chen, M., & Zhou, S. (2024). Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms. ESC Heart Failure. https://doi.org/10.1002/ehf2.14732
Vancouver
Xiao Y, Lai X, Wang Z, Wang S, Wu Z, Liu Q, et al. Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms. ESC Heart Failure. 2024. doi:10.1002/ehf2.14732
BibTeX
@article{Xiao2024,
author = {Xiao, Yichao and Lai, Xin and Wang, Zhuo and Wang, Songyun and Wu, Zhihong and Liu, Qiming and Chen, Mingxian and Zhou, Shenghua},
title = {Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14732}
}
EUVIMED